Brain Advance Access originally published online on April 8, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Brain, Vol. 126, No. 6, 1333-1346,
June 2003
© 2003 Guarantors of Brain
doi: 10.1093/brain/awg125
Molecular classification of sporadic Creutzfeldt–Jakob disease
1 MRC Prion Unit, Department of Neurodegenerative Disease, Institute of Neurology, National Hospital for Neurology and Neurosurgery, London, 2 National CJD Surveillance Unit, University of Edinburgh, Western General Hospital, Edinburgh, UK and 3 Institute of Neurology, University of Vienna, Vienna, Austria 4 Present address: Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, Victoria, Australia
Correspondence to: Professor John Collinge, MRC Prion Unit, Department of Neurodegenerative Disease, Institute of Neurology, Queen Square, London WC1N 3BG, UK E-mail:j.collinge{at}prion.ucl.ac.uk
According to the protein-only hypothesis of prion propagation, an abnormal isoform (designated PrPSc) of the cellular prion protein (PrPC) is the principal or sole component of transmissible prions. However, the existence of multiple prion strains has been difficult to accommodate within this hypothesis. We have previously reported the identification of four types of human PrPSc associated with sporadic and acquired human prion diseases. These PrPSc types are distinguished by differing molecular mass of fragments following limited proteinase K digestion and by differing ratios of di-, mono- and unglycosylated PrPSc. That these discrete biochemical features of PrPSc are serially transmissible to human PrP in transgenic mice following experimental transmission suggests that they may be responsible for encoding prion strain diversity. Here we present detailed clinical, pathological and molecular data from a large number of sporadic Creutzfeldt–Jakob disease (CJD) cases. We show that PrPSc types are associated with codon 129 status, duration of illness and neuropathological phenotype. A novel PrPSc type is presented, illustrating further heterogeneity in CJD, and suggesting that further molecular subtypes of CJD may exist at lower frequencies. A molecular classification of sporadic CJD is proposed.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. W. Head and J. W. Ironside Sporadic Creutzfeldt-Jakob disease: discrete subtypes or a spectrum of disease? Brain, October 1, 2009; 132(10): 2627 - 2629. [Full Text] [PDF]
|
|
|
|
 |
|
 V L Villemagne, C A McLean, K Reardon, A Boyd, V Lewis, G Klug, G Jones, D Baxendale, C L Masters, C C Rowe, et al. 11C-PiB PET studies in typical sporadic Creutzfeldt-Jakob disease J. Neurol. Neurosurg. Psychiatry, September 1, 2009; 80(9): 998 - 1001. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P Clewley, C. M Kelly, N. Andrews, K. Vogliqi, G. Mallinson, M. Kaisar, D. A Hilton, J. W Ironside, P. Edwards, L. M McCardle, et al. Prevalence of disease related prion protein in anonymous tonsil specimens in Britain: cross sectional opportunistic survey BMJ, May 21, 2009; 338(may21_2): b1442 - b1442. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Asante, I. Gowland, A. Grimshaw, J. M. Linehan, M. Smidak, R. Houghton, O. Osiguwa, A. Tomlinson, S. Joiner, S. Brandner, et al. Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins J. Gen. Virol., March 1, 2009; 90(3): 546 - 558. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G Giaccone, G. Di Fede, M. Mangieri, L. Limido, R. Capobianco, S. Suardi, M. Grisoli, S. Binelli, P. Fociani, O. Bugiani, et al. A novel phenotype of sporadic Creutzfeldt-Jakob disease BMJ Case Reports, February 2, 2009; 2009(jan27_1): bcr0920080945 - bcr0920080945. [Abstract] [Full Text]
|
|
|
|
 |
|
 J A Beck, T A Campbell, G Adamson, M Poulter, J B Uphill, E Molou, J Collinge, and S Mead Association of a null allele of SPRN with variant Creutzfeldt-Jakob disease J. Med. Genet., December 1, 2008; 45(12): 813 - 817. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D.F Wadsworth, S. Joiner, J. M Linehan, E. A Asante, S. Brandner, and J. Collinge The origin of the prion agent of kuru: molecular and biological strain typing Phil Trans R Soc B, November 27, 2008; 363(1510): 3747 - 3753. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Brandner, J. Whitfield, K. Boone, A. Puwa, C. O'Malley, J. M Linehan, S. Joiner, F. Scaravilli, I. Calder, M. P. Alpers, et al. Central and peripheral pathology of kuru: pathological analysis of a recent case and comparison with other forms of human prion disease Phil Trans R Soc B, November 27, 2008; 363(1510): 3755 - 3763. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. F. Wadsworth, S. Joiner, J. M. Linehan, M. Desbruslais, K. Fox, S. Cooper, S. Cronier, E. A. Asante, S. Mead, S. Brandner, et al. Kuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type mice PNAS, March 11, 2008; 105(10): 3885 - 3890. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K Murray, D L Ritchie, M Bruce, C A Young, M Doran, J W Ironside, and R G Will Sporadic Creutzfeldt Jakob disease in two adolescents J. Neurol. Neurosurg. Psychiatry, January 1, 2008; 79(1): 14 - 18. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G Giaccone, G Di Fede, M Mangieri, L Limido, R Capobianco, S Suardi, M Grisoli, S Binelli, P Fociani, O Bugiani, et al. A novel phenotype of sporadic Creutzfeldt Jakob disease J. Neurol. Neurosurg. Psychiatry, December 1, 2007; 78(12): 1379 - 1382. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mead, S. Joiner, M. Desbruslais, J. A. Beck, M. O'Donoghue, P. Lantos, J. D. F. Wadsworth, and J. Collinge Creutzfeldt-Jakob Disease, Prion Protein Gene Codon 129VV, and a Novel PrPSc Type in a Young British Woman Arch Neurol, December 1, 2007; 64(12): 1780 - 1784. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mead, T. E. F. Webb, T. A. Campbell, J. Beck, J. M. Linehan, S. Rutherfoord, S. Joiner, J. D. F. Wadsworth, J. Heckmann, S. Wroe, et al. Inherited prion disease with 5-OPRI: Phenotype modification by repeat length and codon 129 Neurology, August 21, 2007; 69(8): 730 - 738. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Ott, A. Akhavan, and V. R. Lingappa Specific Features of the Prion Protein Transmembrane Domain Regulate Nascent Chain Orientation J. Biol. Chem., April 13, 2007; 282(15): 11163 - 11171. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. W. Head and J. W. Ironside Sporadic Creutzfeldt-Jakob disease: further twists and turns in a convoluted protein. Brain, September 1, 2006; 129(Pt 9): 2238 - 2240. [Full Text] [PDF]
|
|
|
|
|
|
I. Cali, R. Castellani, J. Yuan, A. Al-Shekhlee, M. L. Cohen, X. Xiao, F. J. Moleres, P. Parchi, W.-Q. Zou, and P. Gambetti Classification of sporadic Creutzfeldt-Jakob disease revisited. Brain, September 1, 2006; 129(Pt 9): 2266 - 2277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mead, M. Poulter, J. Beck, T. E. F. Webb, T. A. Campbell, J. M. Linehan, M. Desbruslais, S. Joiner, J. D. F. Wadsworth, A. King, et al. Inherited prion disease with six octapeptide repeat insertional mutation--molecular analysis of phenotypic heterogeneity. Brain, September 1, 2006; 129(Pt 9): 2297 - 2317. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Krasnianski, W. J. Schulz-Schaeffer, K. Kallenberg, B. Meissner, D. A. Collie, S. Roeber, M. Bartl, U. Heinemann, D. Varges, H. A. Kretzschmar, et al. Clinical findings and diagnostic tests in the MV2 subtype of sporadic CJD Brain, September 1, 2006; 129(9): 2288 - 2296. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Collins, P. Sanchez-Juan, C. L. Masters, G. M. Klug, C. van Duijn, A. Poleggi, M. Pocchiari, S. Almonti, N. Cuadrado-Corrales, J. de Pedro-Cuesta, et al. Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease Brain, September 1, 2006; 129(9): 2278 - 2287. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Lewis, M. H. Tattum, S. Jones, D. Bhelt, M. Batchelor, A. R. Clarke, J. Collinge, and G. S. Jackson Codon 129 polymorphism of the human prion protein influences the kinetics of amyloid formation. J. Gen. Virol., August 1, 2006; 87(Pt 8): 2443 - 2449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Asante, J. M. Linehan, I. Gowland, S. Joiner, K. Fox, S. Cooper, O. Osiguwa, M. Gorry, J. Welch, R. Houghton, et al. Dissociation of pathological and molecular phenotype of variant Creutzfeldt-Jakob disease in transgenic human prion protein 129 heterozygous mice PNAS, July 11, 2006; 103(28): 10759 - 10764. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Novitskaya, N. Makarava, A. Bellon, O. V. Bocharova, I. B. Bronstein, R. A. Williamson, and I. V. Baskakov Probing the Conformation of the Prion Protein within a Single Amyloid Fibril Using a Novel Immunoconformational Assay J. Biol. Chem., June 2, 2006; 281(22): 15536 - 15545. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. F. Wadsworth, S. Joiner, J. M. Linehan, S. Cooper, C. Powell, G. Mallinson, J. Buckell, I. Gowland, E. A. Asante, H. Budka, et al. Phenotypic heterogeneity in inherited prion disease (P102L) is associated with differential propagation of protease-resistant wild-type and mutant prion protein Brain, June 1, 2006; 129(6): 1557 - 1569. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Novitskaya, O. V. Bocharova, I. Bronstein, and I. V. Baskakov Amyloid Fibrils of Mammalian Prion Protein Are Highly Toxic to Cultured Cells and Primary Neurons J. Biol. Chem., May 12, 2006; 281(19): 13828 - 13836. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. -P. Landolt, M. Glatzel, T. Blattler, P. Achermann, C. Roth, J. Mathis, J. Weis, I. Tobler, A. Aguzzi, and C. L. Bassetti Sleep-wake disturbances in sporadic Creutzfeldt-Jakob disease Neurology, May 9, 2006; 66(9): 1418 - 1424. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Jones, K. Surewicz, and W. K. Surewicz Role of N-terminal Familial Mutations in Prion Protein Fibrillization and Prion Amyloid Propagation in Vitro J. Biol. Chem., March 24, 2006; 281(12): 8190 - 8196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. F. Hill, S. Joiner, J. A. Beck, T. A. Campbell, A. Dickinson, M. Poulter, J. D. F. Wadsworth, and J. Collinge Distinct glycoform ratios of protease resistant prion protein associated with PRNP point mutations Brain, March 1, 2006; 129(3): 676 - 685. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. M. Yull, D. L. Ritchie, J. P.M. Langeveld, F. G. van Zijderveld, M. E. Bruce, J. W. Ironside, and M. W. Head Detection of Type 1 Prion Protein in Variant Creutzfeldt-Jakob Disease Am. J. Pathol., January 1, 2006; 168(1): 151 - 157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Le Dur, V. Beringue, O. Andreoletti, F. Reine, T. L. Lai, T. Baron, B. Bratberg, J.-L. Vilotte, P. Sarradin, S. L. Benestad, et al. A newly identified type of scrapie agent can naturally infect sheep with resistant PrP genotypes PNAS, November 1, 2005; 102(44): 16031 - 16036. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Nishida, S. Katamine, and L. Manuelidis Reciprocal Interference Between Specific CJD and Scrapie Agents in Neural Cell Cultures Science, October 21, 2005; 310(5747): 493 - 496. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Gofflot, M. Deprez, B. el Moualij, A. Osman, J.-F. Thonnart, O. Hougrand, E. Heinen, and W. Zorzi Immunoquantitative PCR for Prion Protein Detection in Sporadic Creutzfeldt-Jakob Disease Clin. Chem., September 1, 2005; 51(9): 1605 - 1611. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Lewis, A. F. Hill, G. M. Klug, A. Boyd, C. L. Masters, and S. J. Collins Australian sporadic CJD analysis supports endogenous determinants of molecular-clinical profiles Neurology, July 12, 2005; 65(1): 113 - 118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Collinge Molecular neurology of prion disease J. Neurol. Neurosurg. Psychiatry, July 1, 2005; 76(7): 906 - 919. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Glatzel, K. Stoeck, H. Seeger, T. Luhrs, and A. Aguzzi Human Prion Diseases: Molecular and Clinical Aspects Arch Neurol, April 1, 2005; 62(4): 545 - 552. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Pan, R. Li, B.-S. Wong, S.-C. Kang, J. Ironside, and M.-S. Sy Novel Antibody-Lectin Enzyme-Linked Immunosorbent Assay That Distinguishes Prion Proteins in Sporadic and Variant Cases of Creutzfeldt-Jakob Disease J. Clin. Microbiol., March 1, 2005; 43(3): 1118 - 1126. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R J Cordery, K Alner, L Cipolotti, M Ron, A Kennedy, J Collinge, and M N Rossor The neuropsychology of variant CJD: a comparative study with inherited and sporadic forms of prion disease J. Neurol. Neurosurg. Psychiatry, March 1, 2005; 76(3): 330 - 336. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hamaguchi, T. Kitamoto, T. Sato, H. Mizusawa, Y. Nakamura, M. Noguchi, Y. Furukawa, C. Ishida, I. Kuji, K. Mitani, et al. Clinical diagnosis of MM2-type sporadic Creutzfeldt-Jakob disease Neurology, February 22, 2005; 64(4): 643 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. G. Kovacs, M. Preusser, M. Strohschneider, and H. Budka Subcellular Localization of Disease-Associated Prion Protein in the Human Brain Am. J. Pathol., January 1, 2005; 166(1): 287 - 294. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. F. Wadsworth, E. A. Asante, M. Desbruslais, J. M. Linehan, S. Joiner, I. Gowland, J. Welch, L. Stone, S. E. Lloyd, A. F. Hill, et al. Human Prion Protein with Valine 129 Prevents Expression of Variant CJD Phenotype Science, December 3, 2004; 306(5702): 1793 - 1796. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Zanusso, A. Farinazzo, F. Prelli, M. Fiorini, M. Gelati, S. Ferrari, P. G. Righetti, N. Rizzuto, B. Frangione, and S. Monaco Identification of Distinct N-terminal Truncated Forms of Prion Protein in Different Creutzfeldt-Jakob Disease Subtypes J. Biol. Chem., September 10, 2004; 279(37): 38936 - 38942. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Lloyd, J. M. Linehan, M. Desbruslais, S. Joiner, J. Buckell, S. Brandner, J. D. F. Wadsworth, and J. Collinge Characterization of two distinct prion strains derived from bovine spongiform encephalopathy transmissions to inbred mice J. Gen. Virol., August 1, 2004; 85(8): 2471 - 2478. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Tahiri-Alaoui, A. C. Gill, P. Disterer, and W. James Methionine 129 Variant of Human Prion Protein Oligomerizes More Rapidly than the Valine 129 Variant: IMPLICATIONS FOR DISEASE SUSCEPTIBILITY TO CREUTZFELDT-JAKOB DISEASE J. Biol. Chem., July 23, 2004; 279(30): 31390 - 31397. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. L. P. Hosszu, G. S. Jackson, C. R. Trevitt, S. Jones, M. Batchelor, D. Bhelt, K. Prodromidou, A. R. Clarke, J. P. Waltho, and J. Collinge The Residue 129 Polymorphism in Human Prion Protein Does Not Confer Susceptibility to Creutzfeldt-Jakob Disease by Altering the Structure or Global Stability of PrPC J. Biol. Chem., July 2, 2004; 279(27): 28515 - 28521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. A. Lawson, S. A. Priola, K. Meade-White, M. Lawson, and B. Chesebro Flexible N-terminal Region of Prion Protein Influences Conformation of Protease-resistant Prion Protein Isoforms Associated with Cross-species Scrapie Infection in Vivo and in Vitro J. Biol. Chem., April 2, 2004; 279(14): 13689 - 13695. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Glatzel, E. Abela, M. Maissen, and A. Aguzzi Extraneural Pathologic Prion Protein in Sporadic Creutzfeldt-Jakob Disease N. Engl. J. Med., November 6, 2003; 349(19): 1812 - 1820. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Budka Neuropathology of prion diseases Br. Med. Bull., June 1, 2003; 66(1): 121 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Wadsworth, A. F Hill, J. A Beck, and J. Collinge Molecular and clinical classification of human prion disease Br. Med. Bull., June 1, 2003; 66(1): 241 - 254. [Abstract] [Full Text] [PDF]
|
|